Cancer shows both sides of the women’s health story. Where there has been steady funding, a vaccine and a screening program, the results are clear. Where there has not, the gaps remain.
Progress: cervical cancer. A virus called HPV (human papillomavirus) causes almost all cases of cervical cancer [1]. Australia vaccinates against HPV and screens for it. Women and people with a cervix aged 25 to 74 are invited to have a Cervical Screening Test every five years, and can choose to collect their own sample [6]. Australia now aims to eliminate cervical cancer as a public health problem by 2035. That means fewer than 4 new cases a year for every 100,000 women [1].
Gap: ovarian cancer. There is no screening test for ovarian cancer. Cancer Australia says no test can yet find it accurately at an early stage, and a Cervical Screening Test does not detect it [3]. In 2017–2021, people diagnosed with ovarian cancer had a 49% chance of surviving five years, compared with the general population. That is up from 36% in 1987–1991 [4].
Gap: treatment side effects. A study of 23,296 patients in 202 US cancer treatment trials found that women were 34% more likely than men to have severe side effects. For immunotherapy, a newer type of cancer treatment, the risk was 49% higher [5].
2035
6.3
0
49%
34%
Why it matters in Australia
The cervical cancer figures show what sustained effort can do. In 2021 the rate of new cases fell to 6.3 for every 100,000 women, from 6.6 the year before. No cases were diagnosed in women under 25, for the first time since records began in 1982. The chance of surviving five years rose to 76.8% in 2017–2021, from 73.9% in 2012–2016 [2]. These figures come from a government media release about the 2025 progress report, not from the report itself.
The work is not finished. The same release says HPV vaccination and cervical screening rates have both fallen slightly [2]. Australia’s targets for 2030 are for 90% of eligible people, girls and boys, to be vaccinated, 70% of eligible people to be screened every five years, and 95% to get treatment when they need it [1].
For ovarian cancer there is no such program to build on. Cancer Australia estimates that 1,929 new cases will be diagnosed in 2025 [4]. The charts below show how many women die from ovarian and cervical cancer each year, and how death rates have changed since 1990.
What needs to change
- Keep vaccination and screening rates up. Both have slipped slightly, and the 2030 targets depend on them [1] [2].
- Reach the women who are screened least. The option to collect your own sample has been taken up by many women who had never or rarely been screened [2].
- Find a way to detect ovarian cancer early. Until a test exists, there can be no screening program for it [3].
- Study how treatments affect women. The authors of the side effects study say the reasons could include how side effects are reported, how the body processes drugs, the total dose given, or how treatment is taken. They call for more research, especially on immunotherapy [5].
If you are worried about symptoms or are due for screening, talk to your GP. Cancer Australia has information on ovarian cancer, and the National Cervical Screening Program explains how screening works.
Global context
The side effects study used US trials run by one research network between 1980 and 2019. It left out cancers that affect only one sex, so it compares women and men having treatment for the same kinds of cancer. It is tagged Global because it is not Australian data [5].
Sources
- National Strategy for the Elimination of Cervical Cancer in Australia. Australian Government Department of Health and Aged Care, 2023.
- Australia on track to eliminate cervical cancer by 2035 (media release on the 2025 Cervical Cancer Elimination Progress Report). Australian Government, 2025.
- Ovarian cancer screening. Cancer Australia.
- Ovarian cancer statistics in Australia. Cancer Australia.
- Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials (Unger JM et al.). Journal of Clinical Oncology, 40(13), 2022.
- National Cervical Screening Program. Australian Government Department of Health, Disability and Ageing.
Last reviewed: [NOT YET REVIEWED]